Home
News
Create
Screeners
Insights
Aspira Pathlab
55.
85
+1.10
(+2.01%)
Market Cap
₹56.30 Cr
PE Ratio
23.50
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
+2.01%
1M
-2.02%
6M
-5.32%
1Y
-37.74%
5Y
+86.79%
View Company Insights
Latest news about Aspira Pathlab
Aspira Pathlab & Diagnostics Limited Sets March 27, 2026 as Record Date for Open Offer Under SEBI Takeover Regulations
5 days ago
Aspira Pathlab & Diagnostics Limited has set March 27, 2026 as the record date for an open offer involving 26,76,180 equity shares at ₹55 per share, representing 26% of the company's equity capital. Five acquirers led by Mr. Arvind Karsandas Bhanushali and family members, along with Mrs. Shraddha Nikunj Mange as PAC, are conducting the offer under SEBI takeover regulations. Aftertrade Broking Private Limited is managing the process, which follows a structured timeline beginning with the public announcement in September 2025.
Aspira Pathlab & Diagnostics Announces Resignation of Company Secretary cum Compliance Officer
Mar 07, 2026
Aspira Pathlab Reports Q3FY26 Net Loss of ₹156.12 Lakhs Against Prior Year Profit
Feb 10, 2026
Aspira Pathlab Submits Quarterly Compliance Certificate for Q3FY26 Under SEBI Regulations
Jan 07, 2026
Aspira Pathlab & Diagnostics Limited Announces Demise of Independent Director Dr. Alaka Keshav Deshpande
Jan 02, 2026
More news about Aspira Pathlab
13
Nov 25
Aspira Pathlab Reports Q2 Loss, Appoints New Independent Director
Aspira Pathlab Diagnostics Limited reported a net loss of ₹230.49 lakhs for the quarter ended September 30, compared to a profit of ₹97.36 lakhs in the same period last year. The company appointed Mrs. Kiran Raghavendra Awasthi as an Additional Independent Director for a five-year term, effective November 12. Aspira Pathlab also acquired the business undertaking of Aspira DNA Diagnostics Gujarat LLP for ₹13.00 lakhs, effective June 30.
26
Sept 25
Aspira Pathlab & Diagnostics Receives Open Offer for 26% Stake at Rs. 55 Per Share
Five acquirers and a person acting in concert have announced an open offer to acquire 26.00% (26,76,180 equity shares) of Aspira Pathlab & Diagnostics Limited at Rs. 55.00 per share. The offer, announced on September 26, 2025, complies with SEBI regulations. Aspira, established in 1973, reported a profit of Rs. 2.07 crores in FY 2024-25, a turnaround from previous year's loss. The company has over 600 centers across India and added 91 new locations in the last fiscal year.
Aspira Pathlab
55.
85
+
1.
10
(+
2.
01
%)
1 Year Returns:
-37.74%
Industry Peers
Dr. Lal Path Labs
1,312.10
(-
1.
00
%)
Vijaya Diagnostic Centre
861.40
(-
1.
02
%)
Metropolis Healthcare
434.00
(+
0.
74
%)
Thyrocare Technologies
349.55
(-
3.
24
%)
Nephrocare Health Services
506.85
(-
3.
32
%)
Krsnaa Diagnostics
520.30
(-
4.
90
%)
Suraksha Diagnostic
227.95
(-
3.
23
%)
One Global Service Provider
486.00
(-
5.
28
%)
3B BlackBio DX
1,124.00
(-
3.
73
%)
Sastasundar Ventures
256.95
(-
6.
51
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO